Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients
NCT ID: NCT02986256
Last Updated: 2020-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2017-01-04
2020-05-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is a monocenter, randomized, in parallel study, in 180 diabetic patients with ulcers of the foot.
Patients included in the conventional group will be followed according to the usual practice Patients included in the "telepied" group will benefit from a personalized accompaniment by a nurse referring to diabetic foot ulcers who will guide and advise the nurse at home by acting by delegating tasks of the investigator.
The patient will be visited by the referring nurse every 15 days. During these visits, the referring nurse will have the objective to evaluate the evolution of the ulcer as well as the care performed. This visit also allows a close personalized accompaniment for the patient, who will benefit from an education adapted to the characteristics of ulcer (discharge modalities for example ..) and its way of life.
Every patients will be followed for one year (12 months).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management
NCT01814267
The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care
NCT02818322
Effectiveness and Safety of Antibiotherapy in Diabetic Patients Treated for a Diabetic Foot Infection.
NCT03495349
Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers
NCT01710774
Prevention of Secondary Foot Ulcers in Patients With Diabetes Using Systematic Measuring of Skin Temperature.
NCT01269502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventionnal Group
No intervention for this group. Patients will be followed by a usual care.
No interventions assigned to this group
"Telepied" Group
Patients will be followed by a nurse referring to ulcers of the diabetic foot.
Taking pictures
Photograph of foot ulcer with transmission to referring nurse 1 time per week
Visit at home
Home visit by the referring nurse every 15 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taking pictures
Photograph of foot ulcer with transmission to referring nurse 1 time per week
Visit at home
Home visit by the referring nurse every 15 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetic patients with foot ulcer
* Patient who agreed to participate in the study and sign free and informed consent
* Patient affiliated to a social security scheme
Exclusion Criteria
* Patient deprived of liberty by a judicial or administrative decision or a person subject to a legal protection measure
* Patient already involved in another clinical trial protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dured Dardari, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Sud Francilien
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud-Francilien
Corbeil-Essonnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A01136-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.